| Seo Yeon Lee, PHARMD | |
|
505 City Pkwy W, Orange, CA 92868-2924 | |
| (657) 900-1155 | |
| Not Available |
| Full Name | Seo Yeon Lee |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 505 City Pkwy W, Orange, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023890449 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 76774 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Seo Yeon Lee, PHARMD 505 City Pkwy W, Orange, CA 92868-2924 Ph: () - | Seo Yeon Lee, PHARMD 505 City Pkwy W, Orange, CA 92868-2924 Ph: (657) 900-1155 |
News Archive
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it completed its pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a proposed IND (Investigative New Drug) to evaluate the safety and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
Any discussion of health care runs the risk of deteriorating into generalities. So let me be specific: We must reduce wait times. Canadians need to know, Wherever they live, how long it takes to get an MRI, how long it takes to see a doctor, to get needed hip surgery, and how quickly their child will be seen in the emergency ward.
The GOP leaders of the House Ways and Means Committee are "determined" to solve the "Sustainable Growth Rate problem" this year. Meanwhile, House Democrats are reviving a bill to prevent some workers from avoiding Medicare taxes.
A Medical College of Wisconsin and Children's Research Institute team in Milwaukee has created a free, searchable genetic database that will significantly improve diagnostic testing and genetic tracking of human and animal influenza viruses.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
› Verified 6 days ago
Joanne S Lau, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 City Pkwy W Ste 800, Orange, CA 92868 Phone: 714-347-5858 | |
Ali Shishehgar, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 132 S Anita Dr Ste 310, Orange, CA 92868 Phone: 877-778-3773 | |
Mrs. Stephanie Tram Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 W La Veta Ave, Orange, CA 92868 Phone: 714-509-8856 Fax: 714-509-4371 | |
Travis Stucky, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1538 E Chapman Ave, Orange, CA 92866 Phone: 714-288-1790 | |
Dr. William Robert Truong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8000 | |
Christine Jung, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 City Pkwy W Ste 800, Orange, CA 92868 Phone: 657-236-5153 Fax: 714-560-7627 | |
Terrie Liu Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8968 |